{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:02:53Z","timestamp":1785225773300,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"La Caixa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013941","name":"Biomedical Research Network Centre of Diabetes and Associated Metabolic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.redox.2026.104286","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:34:12Z","timestamp":1783035252000},"page":"104286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A hypothalamus-liver-skeletal muscle axis controlled by JNK1 and FGF21 mediates olanzapine-induced insulin resistance in an intraperitoneal treatment in male mice"],"prefix":"10.1016","volume":"95","author":[{"given":"Vitor","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Folgueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Hitos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Montes San-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1nxela","family":"Est\u00e9vez-Salguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Porteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Sabio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-2098","authenticated-orcid":false,"given":"Patricia","family":"Rada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela M.","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104286_bib1","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel","year":"2014","journal-title":"P T"},{"key":"10.1016\/j.redox.2026.104286_bib2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0706743717720448","article-title":"Guidelines for the pharmacotherapy of schizophrenia in adults","volume":"62","author":"Remington","year":"2017","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.redox.2026.104286_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13347","article-title":"Metabolic effects of atypical antipsychotics: molecular targets","volume":"35","author":"Fonseca","year":"2023","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.redox.2026.104286_bib4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2337\/diacare.29.04.06.dc05-1261","article-title":"Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders","volume":"29","author":"Cohen","year":"2006","journal-title":"Diabetes Care"},{"issue":"Suppl 18","key":"10.1016\/j.redox.2026.104286_bib5","first-page":"27","article-title":"Dyslipidemia and atypical antipsychotic drugs","volume":"65","author":"Casey","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 7","key":"10.1016\/j.redox.2026.104286_bib6","first-page":"32","article-title":"The clinical implications of weight gain in schizophrenia","volume":"62","author":"Kurzthaler","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.redox.2026.104286_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2026.104286_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2016.16040442","article-title":"Endogenous and antipsychotic-related risks for diabetes mellitus in young people with schizophrenia: a Danish population-based cohort study","volume":"174","author":"Rajkumar","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.redox.2026.104286_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2008.03.003","article-title":"Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study","volume":"34","author":"Oriot","year":"2008","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.redox.2026.104286_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.redox.2026.104286_bib11","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4088\/JCP.v64n1206","article-title":"Olanzapine induces insulin resistance: results from a prospective study","volume":"64","author":"Ebenbichler","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.redox.2026.104286_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41386-021-01244-7","article-title":"Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers","volume":"47","author":"Toledo","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.redox.2026.104286_bib13","article-title":"Adipose tissue as a target for second-generation (atypical) antipsychotics: a molecular view","volume":"1865","author":"Ferreira","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.redox.2026.104286_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111336","article-title":"Second-generation antipsychotics and dysregulation of glucose metabolism: beyond weight gain","volume":"8","author":"Grajales","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.redox.2026.104286_bib15","article-title":"Understanding the effects of antipsychotics on appetite control","volume":"8","author":"Mukherjee","year":"2021","journal-title":"Front. Nutr."},{"key":"10.1016\/j.redox.2026.104286_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155335","article-title":"Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight","volume":"137","author":"Ferreira","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.redox.2026.104286_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.redox.2026.104286_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0091-3057(93)90084-7","article-title":"Effects of long-term administration of clozapine on body weight and food intake in rats","volume":"45","author":"Baptista","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.redox.2026.104286_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lfs.2007.08.009","article-title":"Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats","volume":"81","author":"Choi","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2026.104286_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/026988110201600402","article-title":"Characterization of olanzapine-induced weight gain in rats","volume":"16","author":"Goudie","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.redox.2026.104286_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.appet.2006.01.008","article-title":"Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration","volume":"46","author":"Minet-Ringuet","year":"2006","journal-title":"Appetite"},{"key":"10.1016\/j.redox.2026.104286_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050853","article-title":"Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment","volume":"7","author":"Skrede","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104286_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","article-title":"Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design","volume":"127","author":"Coccurello","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.redox.2026.104286_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pnpbp.2010.04.024","article-title":"A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model","volume":"34","author":"Boyda","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.redox.2026.104286_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00213-008-1415-1","article-title":"Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine","volume":"203","author":"Davoodi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.redox.2026.104286_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-007-0833-9","article-title":"The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats","volume":"194","author":"Fell","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.redox.2026.104286_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/21623945.2022.2026590","article-title":"The mechanisms underlying olanzapine-induced insulin resistance via the brown adipose tissue and the therapy in rats","volume":"11","author":"Wang","year":"2022","journal-title":"Adipocyte"},{"key":"10.1016\/j.redox.2026.104286_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41598-018-36930-y","article-title":"Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104286_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110912","article-title":"Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats","volume":"133","author":"Guo","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2026.104286_bib30","article-title":"Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes","volume":"7","author":"Dipta","year":"2021","journal-title":"Compr. Psychoneuroendocrinol."},{"key":"10.1016\/j.redox.2026.104286_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043244","article-title":"Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance","volume":"7","author":"Girault","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104286_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lfs.2018.12.015","article-title":"The IRS\/PI3K\/Akt signaling pathway mediates olanzapine-induced hepatic insulin resistance in male rats","volume":"217","author":"Ren","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2026.104286_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104413","article-title":"Female mice are protected against acute olanzapine-induced hyperglycemia","volume":"110","author":"Medak","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.redox.2026.104286_bib34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.psyneuen.2017.12.004","article-title":"Obesity exacerbates the acute metabolic side effects of olanzapine","volume":"88","author":"Townsend","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.redox.2026.104286_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.mp.4001729","article-title":"Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells","volume":"10","author":"Engl","year":"2005","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.redox.2026.104286_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/db09-0796","article-title":"Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice","volume":"59","author":"Gonzalez-Rodriguez","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104286_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1474-9726.2011.00786.x","article-title":"Essential role of protein tyrosine phosphatase 1B in obesity-induced inflammation and peripheral insulin resistance during aging","volume":"11","author":"Gonzalez-Rodriguez","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.redox.2026.104286_bib38","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/mnfr.201400933","article-title":"Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner","volume":"59","author":"Gonzalez-Rodriguez","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.redox.2026.104286_bib39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2337\/db08-0913","article-title":"Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress","volume":"58","author":"Delibegovic","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104286_bib40","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","article-title":"Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice","volume":"20","author":"Klaman","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2026.104286_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102741","article-title":"Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: additional effects of PTP1B inhibition","volume":"63","author":"Ferreira","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104286_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116138","article-title":"Neuroinflammation as a common denominator of complex diseases (Cancer, diabetes type 2, and neuropsychiatric disorders)","volume":"22","author":"Asslih","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104286_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101263","article-title":"Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases","volume":"26","author":"Garcia-Ruiz","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104286_bib44","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2013"},{"key":"10.1016\/j.redox.2026.104286_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance","volume":"16","author":"Lopez","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2026.104286_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2014.03.031","article-title":"Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK","volume":"20","author":"Martinez de Morentin","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104286_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cmet.2017.06.014","article-title":"Hypothalamic AMPK-ER Stress-JNK1 axis mediates the central actions of thyroid hormones on energy balance","volume":"26","author":"Martinez-Sanchez","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104286_bib48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.32581","article-title":"Myeloid p38 activation maintains macrophage-liver crosstalk and BAT thermogenesis through IL-12-FGF21 axis","volume":"77","author":"Crespo","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2026.104286_bib49","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/schbul\/sbn104","article-title":"Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation","volume":"36","author":"Savoy","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.redox.2026.104286_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145713000795","article-title":"Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats","volume":"17","author":"Boyda","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.redox.2026.104286_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.138","article-title":"Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways","volume":"3","author":"Mondelli","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.redox.2026.104286_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.psyneuen.2018.05.021","article-title":"Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue","volume":"95","author":"Calevro","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.redox.2026.104286_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167227","article-title":"Estrogens prevent the hypothalamus-periphery crosstalk induced by olanzapine intraperitoneal treatment in female mice: effects on brown\/beige adipose tissues and liver","volume":"1870","author":"Ferreira","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.redox.2026.104286_bib54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000356119","article-title":"Olanzapine-induced hyperglycemia: possible involvement of histaminergic, dopaminergic and adrenergic functions in the central nervous system","volume":"98","author":"Ikegami","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.redox.2026.104286_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102045","article-title":"Protein kinase D2 modulates hepatic insulin sensitivity in male mice","volume":"90","author":"Rada","year":"2024","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2026.104286_bib56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fct.2018.11.019","article-title":"Differential effects of metformin glycinate and hydrochloride in glucose production, AMPK phosphorylation and insulin sensitivity in hepatocytes from non-diabetic and diabetic mice","volume":"123","author":"Rada","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.redox.2026.104286_bib57","first-page":"1097","article-title":"Olanzapine pharmacokinetics: a clinical review of Current insights and remaining questions","volume":"16","author":"Kolli","year":"2023","journal-title":"Pharmgenomic. Pers. Med."},{"key":"10.1016\/j.redox.2026.104286_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030706","article-title":"Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes","volume":"9","author":"Yung","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.redox.2026.104286_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","article-title":"A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance","volume":"2","author":"Bruning","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2026.104286_bib60","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/j.2040-4603.2020.tb00136.x","article-title":"Role of skeletal muscle in insulin resistance and glucose uptake","volume":"10","author":"Merz","year":"2020","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.redox.2026.104286_bib61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.06.010","article-title":"The PPARalpha-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway","volume":"20","author":"Vernia","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104286_bib62","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2026.104286_bib63","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1172\/JCI93362","article-title":"The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C","volume":"127","author":"Lord","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2026.104286_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ijnp\/pyx073","article-title":"Lack of ovarian secretions reverts the anabolic action of olanzapine in female rats","volume":"20","author":"Skrede","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.redox.2026.104286_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.mcn.2007.05.009","article-title":"Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases","volume":"36","author":"Levkovitz","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.redox.2026.104286_bib66","doi-asserted-by":"crossref","first-page":"F1622","DOI":"10.1152\/ajprenal.00078.2009","article-title":"Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells","volume":"297","author":"Wu","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.redox.2026.104286_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's Disease","volume":"2015","author":"Verdile","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.redox.2026.104286_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2026.104286_bib69","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tibs.2010.04.004","article-title":"cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance","volume":"35","author":"Sabio","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.redox.2026.104286_bib70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00125-020-05327-w","article-title":"Brain JNK and metabolic disease","volume":"64","author":"Nogueiras","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2026.104286_bib71","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1073\/pnas.1001796107","article-title":"Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism","volume":"107","author":"Belgardt","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2026.104286_bib72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","article-title":"TNF and MAP kinase signalling pathways","volume":"26","author":"Sabio","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.redox.2026.104286_bib73","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2026.104286_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112071","article-title":"JNK downregulation improves olanzapine-induced insulin resistance by suppressing IRS1(Ser307) phosphorylation and reducing inflammation","volume":"142","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2026.104286_bib75","article-title":"Fibroblast growth factor 21: an emerging pleiotropic regulator of lipid metabolism and the metabolic network","volume":"11","author":"Li","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.redox.2026.104286_bib76","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","article-title":"FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues","volume":"23","author":"Schlein","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104286_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1692742","article-title":"Metabolic crossroads in insulin resistance: exploring lipid dysregulation and inflammation","volume":"16","author":"Saadati","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104286_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2018.12.031","article-title":"CerS1-Derived C(18:0) ceramide in skeletal muscle promotes obesity-induced insulin resistance","volume":"26","author":"Turpin-Nolan","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2026.104286_bib79","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/en.2013-1191","article-title":"Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice","volume":"154","author":"Camporez","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.redox.2026.104286_bib80","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.redox.2026.104286_bib81","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1074\/jbc.M800061200","article-title":"Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo","volume":"283","author":"Zabolotny","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104286_bib82","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1128\/MCB.00959-07","article-title":"Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B","volume":"27","author":"Delibegovic","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2026.104286_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105397","article-title":"Ketamine's schizophrenia-like effects are prevented by targeting PTP1B","volume":"155","author":"Qin","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2026.104286_bib84","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1503\/jpn.170092","article-title":"In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact","volume":"42","author":"Kowalchuk","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.redox.2026.104286_bib85","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.2337\/db17-1538","article-title":"SF1-Specific AMPKalpha1 deletion protects against diet-induced obesity","volume":"67","author":"Seoane-Collazo","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104286_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102170","article-title":"JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism","volume":"98","author":"Fernandez-Gonzalez","year":"2025","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2026.104286_bib87","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","article-title":"PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis","volume":"280","author":"Tiganis","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2026.104286_bib88","first-page":"573","article-title":"Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys","volume":"25","author":"Mattiuz","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.redox.2026.104286_bib89","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.redox.2026.104286_bib90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine. Pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:47:30Z","timestamp":1785224850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":90,"alternative-id":["S2213231726002855"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104286","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hypothalamus-liver-skeletal muscle axis controlled by JNK1 and FGF21 mediates olanzapine-induced insulin resistance in an intraperitoneal treatment in male mice","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104286"}}